May 5, 2025 - 11:05

Recursion has announced its financial results for the first quarter of 2025, highlighting significant advancements in its research and development strategy. The company has successfully streamlined its portfolio, focusing on more than five clinical and preclinical programs specifically targeting oncology and rare diseases. This shift comes after a thorough, data-driven review that led to the deprioritization of three clinical programs and one preclinical program, reflecting a commitment to enhancing operational efficiency and effectiveness.
In addition to its internal developments, Recursion has made strides in partnerships, notably achieving its fourth milestone in collaboration with Sanofi. This milestone has resulted in a financial boost of $7 million, associated with an orally active small-molecule lead that shows promise as a best-in-class treatment for autoimmune diseases.
The company's ongoing efforts to refine its platform and operations demonstrate its dedication to innovation and growth in the pharmaceutical landscape, positioning it well for future success.
May 25, 2026 - 17:49
Facebook group supporting Black-owned businesses grows into real-world community hub | ChicagoNOWA Facebook group that began as a simple way to support Black-owned businesses has evolved into a physical community hub, raising over $100,000 in the process. The group, which started with a focus...
May 25, 2026 - 11:29
BUSINESS BRIEFS May 25, 2025: Business news in the Berkshires and beyondA wave of financial activity is reshaping the Berkshire business landscape as local institutions announce leadership changes, new services, and community investments. Beacon Bank has promoted two...
May 24, 2026 - 23:26
Business People: Pakou Yang to lead Normandale Community CollegeThe Minnesota State Colleges and Universities system has officially appointed Pakou Yang as the new president of Normandale Community College in Bloomington. Yang, who has been serving as the...
May 24, 2026 - 04:35
Nvidia’s Hidden $60 Billion Business Is About to Overtake BroadcomFor years, investors treated artificial intelligence as a simple GPU story. Buy the chipmakers, ride the boom, and call it a day. But AI data centers have evolved into something much bigger -...